Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Jul 1.

Published in final edited form as: Osteoporos Int. 2016 Aug 22;28(1):77–84. doi: 10.1007/s00198-016-3721-5

Table 2. Associations between self-efficacy scores at 14 weeks, PETS and compliance.

	Placebo		Cholecalciferol 1000 IU/d		Whole group
Outcomes	OR (95% CI)	p	OR (95% CI)	p	OR (95% CI)	p
Practical problems (Yes vs. No)	0.81 (0.64,1.02)	0.07	0.80 (0.64,1.01)	0.06	0.81 (0.69,0.95)	0.01
Uncertainty (Yes vs. No)	0.90 (0.67,1.22)	0.51	1.00 (0.75,1.33)	0.99	0.95 (0.77,1.17)	0.64
Doubts (Yes vs. No)	0.91 (0.66,1.24)	0.54	0.87 (0.65,1.18)	0.38	0.89 (0.71,1.10)	0.28
	r		r		r
Compliance (SD)	0.04	0.66	0.07	0.49	0.05	0.43